{
    "clinical_study": {
        "@rank": "89164", 
        "acronym": "COMBINE", 
        "arm_group": [
            {
                "arm_group_label": "Budesonide/indacaterol", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive a fixed combination of fluticasone and salmeterol during 4 weeks followed by a free combination of budesonide and indacaterol for the remainig of study."
            }, 
            {
                "arm_group_label": "Fluticasone / salmeterol", 
                "arm_group_type": "Active Comparator", 
                "description": "Fixed combination of fluticasone and salmeterol"
            }
        ], 
        "brief_summary": {
            "textblock": "To demonstrate the free combination of budesonide and indacaterol is as efficacious as\n      fluticasone and salmeterol in patients with COPD"
        }, 
        "brief_title": "Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent must be obtained before any assessment is performed\n\n          -  Outpatients with stable COPD groups C and D according to the 2011 GOLD Guidelines.\n\n          -  Current or ex-smokers who have a smoking history of at least 10 pack years\n\n          -  Patients with a history of at least one exacerbation.\n\n          -  Patients able to read and complete\n\n        Exclusion Criteria:\n\n          -  Use of other investigational drugs within 30 days\n\n          -  Patients with a history of hypersensitivity to any of the study drugs\n\n          -  History or current diagnosis of ECG abnormalities\n\n          -  Patients with diabetes Type I or uncontrolled diabetes Type II including patients\n             with a history of blood glucose levels consistently outside the normal range\n\n          -  Patients who have not achieved an acceptable spirometry result at Visit 1\n\n          -  Patients with a body mass index (BMI) of more than 40 kg/m2\n\n          -  Patients with lung cancer or a history of lung cancer\n\n          -  Patients with a history of malignancy of any organ system\n\n          -  Pregnant or nursing (lactating) women\n\n          -  Women of child-bearing potential, defined as all women physiologically capable of\n             becoming pregnant, unless they are using effective methods of contraception during\n             dosing of study treatment\n\n          -  Patients who do not maintain regular day/night, waking/sleeping cycles (e.g., night\n             shift workers)\n\n          -  Patients that are uncontrolled or unstable on permitted therapy, who in the opinion\n             of the investigator, have clinically significant renal, cardiovascular, neurological,\n             endocrine, immunological, psychiatric, gastrointestinal, hepatic, or haematological\n             abnormalities which could interfere with the assessment of the efficacy and safety of\n             the study treatment\n\n          -  Patients requiring oxygen therapy for chronic hypoxemia\n\n          -  Patients who have had a respiratory tract infection within 6 weeks prior to Visit 1\n\n          -  Patients with concomitant pulmonary disease, e.g. pulmonary tuberculosis,\n             bronchiectasis, sarcoidosis, interstitial lung disorder or pulmonary hypertension\n\n          -  Patients with a known diagnosis of Alpha-1 Antitrypsin deficiency.\n\n          -  Patients with history of lung surgery\n\n          -  Patients who are participating in the active phase of a supervised pulmonary\n             rehabilitation program.\n\n          -  Patients with a history of asthma Other protocol-defined inclusion/exclusion criteria\n             may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02055352", 
            "org_study_id": "CQAB149BAR01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Budesonide/indacaterol", 
                "description": "Budesonide 400 mcg twice a day via Breezhaler\u00ae device", 
                "intervention_name": "Budesonide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Budesonide/indacaterol", 
                    "Fluticasone / salmeterol"
                ], 
                "description": "Fluticasone 250 mcg twice daily via Accuhaler\u00ae device", 
                "intervention_name": "Fluticasone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Budesonide/indacaterol", 
                "description": "Indacaterol 150 mcg once daily via Breezhaler\u00ae device", 
                "intervention_name": "Indacaterol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Budesonide/indacaterol", 
                    "Fluticasone / salmeterol"
                ], 
                "description": "Salmeterol 50 mcg twice daily via Diskus\u00ae device", 
                "intervention_name": "Salmeterol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Budesonide", 
                "Salmeterol", 
                "Albuterol", 
                "Fluticasone", 
                "Fluticasone, salmeterol drug combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "C1056ABJ"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "C1280AEB"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Florida", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "B1602DQD"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Plata", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "1900"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vicente Lopez", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "B1638AAI"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zarate", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "2800"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Rosa", 
                        "country": "Argentina", 
                        "state": "La Pampa"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1425"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "C1125ABE"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salta", 
                        "country": "Argentina", 
                        "zip": "4000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "20551-030"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "021941-617"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90880-480"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Bernardo do Campo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "09750-420"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "01244-030"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santo Domingo", 
                        "country": "Dominican Republic", 
                        "state": "Republica Dominicana", 
                        "zip": "10205"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santo Domingo", 
                        "country": "Dominican Republic", 
                        "state": "Republica Dominicana"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cuenca", 
                        "country": "Ecuador", 
                        "state": "Azuay"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guayaquil", 
                        "country": "Ecuador", 
                        "state": "Guayas", 
                        "zip": "412"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quito", 
                        "country": "Ecuador", 
                        "state": "Pichincha", 
                        "zip": "1701"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portoviejo", 
                        "country": "Ecuador"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Pedro Sula", 
                        "country": "Honduras"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tegucigalpa", 
                        "country": "Honduras"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Panama City", 
                        "country": "Panama", 
                        "state": "Panam\u00e1"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Panama City", 
                        "country": "Panama", 
                        "state": "Panam\u00e1"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Argentina", 
                "Brazil", 
                "Dominican Republic", 
                "Ecuador", 
                "Honduras", 
                "Panama"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "24-week Study to Evaluate Efficacy and Safety of the Combination Budesonide / Indacaterol vs Fluticasone / Salmeterol in Patients With COPD", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+41613241111"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica", 
                "Brazil: National Committee of Ethics in Research", 
                "Chile: Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica", 
                "Dominican Republic: Consejo Nacional de Bioetica en Salud", 
                "Ecuador: Public Health Ministry", 
                "Honduras: Public Health Ministry", 
                "Mexico: Ministry of Health", 
                "Panama: Ministry of Health", 
                "Venezuela: Ministry of Health and Social Development"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Forced Expiratory Volume in 1 second (FEV1) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation.", 
            "measure": "Change from baseline in trough Forced Expiratory Volume in 1 second", 
            "safety_issue": "No", 
            "time_frame": "Baseline and week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02055352"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Modified Medical Research Council scale (mMRC) questionnaire will be completed by participants", 
                "measure": "Change in Health status - mMRC", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 12 and week 24"
            }, 
            {
                "description": "Number of times of rescue medication use will be collected via diaries.", 
                "measure": "Percent use of rescue medications", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "All Adverse events will be documented and reported", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Forced Expiratory Volume in 1 second (FEV1) is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation.", 
                "measure": "Change from baseline in trough Forced Expiratory Volume in 1 second at week 24", 
                "safety_issue": "No", 
                "time_frame": "Baseline and week 24"
            }, 
            {
                "description": "St George's Respiratory Questionnaire short version questionnaire will be completed by participants", 
                "measure": "Change in Health status - SGRQ-C", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 12 and week 24"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}